TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease: Impaired B cell maturation in mice lacking BLyS

Immunity

Volumn 15, Issue 2, 2001, Pages 289-302

  Gross, Jane A ^a   Dillon, Stacey R ^a   Mudri, Sherri ^a   Johnston, Janet ^a   Littau, Alisa ^a   Roque, Richard ^a   Rixon, Mark ^a   Schou, Ole ^a   Foley, Kevin P ^a   Haugen, Harald ^a   McMillen, Susan ^a   Waggie, Kim ^a   Schreckhise, Randy W ^a   Shoemaker, Kim ^b   Vu, Tuyen ^b   Moore, Margaret ^a   Grossman, Angelika ^a   Clegg, Chris H ^a  

^a Department of Immunology ^*  (United States)

^b ZYMOGENETICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COLLAGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN TCAI; PROTEIN; PROTEIN BLYS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL MATURATION; CIRCULATION; CONTROLLED STUDY; DISEASE COURSE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTE TRANSFORMATION; MALE; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TRANSGENIC MOUSE;

EID: 17944375043     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(01)00183-2     Document Type: Article

References (49)

1. Development of B-1 cells: Segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression
2. BAFF mediates survival of peripheral immature B lymphocytes
3. TACI is expressed on a subset of human B-lymphomas and may enhance tumor survival
4. The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region
5. Serum levels of B lymphocyte stimulator (BLyS) are elevated in patients with systemic immune-based rheumatologic disorders
6. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases
7. The complexity of signaling pathways activated by the BCR
8. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response
9. Localization of the binding site for the human high-affinity Fc receptor on IgG
10. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
11. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response
12. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth
13. B cell development pathways
14. B-cell subpopulations identified by two-colour fluorescence analysis
15. Distinctive developmental origins and specificities of murine CD5+ B cells
16. Development and function of B-1 cells
17. B lymphocyte developmental lineages
18. Evidence for an underlying CD4 helper and CD8 T-cell defect in B-cell-deficient mice: Failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice
19. Lymphocyte survival - Ignorance is BLys
20. A role for B cells in the development of T cell helper function in a malaria infection in mice
21. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals
22. Knock-out mouse for Canavan disease: A model for gene transfer to the central nervous system
23. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations
24. The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily
25. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI
26. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory"
27. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk
28. Positive and negative selection events during B lymphopoiesis
29. BLyS: Member of the tumor necrosis factor family and B lymphocyte stimulator
30. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses
31. A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth
32. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth
33. The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex
34. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA)
35. Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation
36. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
37. BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population
38. Aberrant B cell development and immune response in mice with a compromised BCR complex
39. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk
40. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily
41. APRIL and BAFF connect autoimmunity and cancer
42. Construction of gene targeting vectors from lambda KOS genomic libraries
43. The IgG Fc contains distinct Fc receptor (FcR) binding sites: The leukocyte receptors Fc gamma RI and Fc gamma RIIa bind to a region in the Fc distinct from that recognized by neonatal FcR and protein A
44. Cutting edge commentary: Origins of B-1 cells
45. Tumor necrosis factor (TNF) receptor superfamily member TACI is a high affinity receptor for TNF family members APRIL and BLyS
46. Identification of a receptor for BLyS demonstrates a crucial role in humoral immunity
47. Signaling through the B cell antigen receptor in developing B cells
48. APRIL and TALL-I and receptors BCMA and TACI: System for regulating humoral immunity
49. Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus